Q Biomed Inc. Reports on Current and New Potential Assets
Q BioMed Inc., a biotechnology acceleration company is pleased to report on new potential asset license/acquisition and an update on Man 01 development.Q BioMed Inc. Congratulates Mannin Research on Selection to the Chicago-Canada Mentorship Program (C2MP) and Inaugural Meeting
Q BioMed Inc., a biotechnology acceleration company is pleased to congratulate Mannin Research on its selection to the C2MP program and the exceptional mentors and advisors now included in the long list of industry experts available to assist in advancing these important technologies.Q Biomed Inc. Appoints David Laskow-Pooley to Management Team
Q BioMed Inc., a biotechnology acceleration company is pleased to welcome David Laskow-Pooley to the Q Team as VP Scientific & Product Development.Q BioMed Inc. and Mannin Research Inc Sign Definitive License Agreement
Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.